Cargando…

Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer

OBJECTIVE: To examine the effectiveness of systemic chemotherapy following radical hysterectomy for women with intermediate-risk stage IB cervical cancer. MATERIALS AND METHODS: This is a retrospective analysis of a previously organized nation-wide cohort study examining 6,003 women with stage IB-II...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuo, Koji, Shimada, Muneaki, Yokota, Harushige, Satoh, Toyomi, Katabuchi, Hidetaka, Kodama, Shoji, Sasaki, Hiroshi, Matsumura, Noriomi, Mikami, Mikio, Sugiyama, Toru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739780/ https://www.ncbi.nlm.nih.gov/pubmed/29290995 http://dx.doi.org/10.18632/oncotarget.22437

Ejemplares similares

Ovarian conservation for young women with clinical stage IB–IIB cervical cancer in Japan
por: Matsuo, Koji, et al.
Publicado: (2017)

Neoadjuvant Chemotherapy with Taxane and Platinum Followed by Radical Hysterectomy for Stage IB2-IIB Cervical Cancer: Impact of Histology Type on Survival
por: Matsuo, Koji, et al.
Publicado: (2019)

Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB–IIB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2018)

Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: A treatment implication during the coronavirus pandemic
por: Matsuo, Koji, et al.
Publicado: (2021)

Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis
por: Chiyoda, Tatsuyuki, et al.
Publicado: (2020)

The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
por: Tokunaga, Hideki, et al.
Publicado: (2021)

Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study)
por: Nakamura, Kazuto, et al.
Publicado: (2016)

Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study
por: Matsuo, Koji, et al.
Publicado: (2019)

Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB–IIB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2018)

Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan
por: Machida, Hiroko, et al.
Publicado: (2019)

Surgically treated cervical cancer in a high-risk group in the era of the 2018 FIGO staging schema: a nationwide study
por: Shigeta, Shogo, et al.
Publicado: (2023)

Trachelectomy for stage IB1 cervical cancer with tumor size >2 cm: trends and characteristics in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

Practice patterns of adjuvant therapy for intermediate/high recurrence risk cervical cancer patients in Japan
por: Ikeda, Yuji, et al.
Publicado: (2016)

Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study
por: Machida, Hiroko, et al.
Publicado: (2021)

The use of conization to identify and treat severe lesions among prediagnosed CIN1 and 2 patients in Japan
por: Mikami, Mikio, et al.
Publicado: (2018)

Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology
por: Mikami, Mikio, et al.
Publicado: (2017)

A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma
por: Yamagami, Wataru, et al.
Publicado: (2020)

Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer
por: Mikami, Mikio, et al.
Publicado: (2018)

Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate‐risk group
por: Taguchi, Ayumi, et al.
Publicado: (2023)

Homologous recombination inquiry through ovarian malignancy investigations: JGOG3025 Study
por: Yoshihara, Kosuke, et al.
Publicado: (2023)

Association of menopause, aging and treatment procedures with positive margins after therapeutic cervical conization for CIN 3: a retrospective study of 8,856 patients by the Japan Society of Obstetrics and Gynecology
por: Ikeda, Masae, et al.
Publicado: (2021)

Critical evaluation on roles of macrophagic myofasciitis and aluminum adjuvants in HPV vaccine–induced adverse events
por: Matsumura, Noriomi, et al.
Publicado: (2023)

Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer
por: Kanao, Hiroyuki, et al.
Publicado: (2019)

Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052)
por: Asano, Hiroshi, et al.
Publicado: (2022)

Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery: SGSG/TGCU Intergroup Surveillance
por: SHIMADA, MUNEAKI, et al.
Publicado: (2013)

Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
por: Nogami, Yuya, et al.
Publicado: (2021)

Analysis of pathological and clinical characteristics of cervical conization according to age group in Japan
por: Murakami, Isao, et al.
Publicado: (2020)

The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee
por: Ikeda, Masae, et al.
Publicado: (2021)

Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
por: Machida, Hiroko, et al.
Publicado: (2019)

Application of deep learning to the classification of images from colposcopy
por: Sato, Masakazu, et al.
Publicado: (2018)

Radical resection of an endometrioid carcinoma arising from endometriosis in the round ligament within the right canal of Nuck: a case report and literature review
por: Motooka, Yashiro, et al.
Publicado: (2018)

Neoadjuvant chemotherapy using platinum- and taxane-based regimens for bulky stage Ib2 to IIb non-squamous cell carcinoma of the uterine cervix
por: Shoji, Tadahiro, et al.
Publicado: (2012)

Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas
por: Matsuo, Koji, et al.
Publicado: (2023)

Cisplatin concurrent chemoradiotherapy vs adjuvant radiation in stage IB/IIA cervical cancer with intermediate risk factors, treated with radical surgery: a retrospective study
por: Sun, Hai-Yan, et al.
Publicado: (2018)

Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee
por: Shigeta, Shogo, et al.
Publicado: (2017)

Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
por: Yamagami, Wataru, et al.
Publicado: (2019)

Role of adjuvant treatment in stage IB non-small cell lung carcinoma
por: Park, Cheol-Kyu, et al.
Publicado: (2023)

Successful outcome following detection and removal of a very small ovarian teratoma associated with anti‐NMDA receptor encephalitis during pregnancy
por: Mizutamari, Etsuko, et al.
Publicado: (2016)

Detection of Human Papillomavirus Types 6/11, 16 and 18 in Exfoliated Cells from the Uterine Cervices of Japanese Women with and without Lesions
por: Yokota, Harushige, et al.
Publicado: (1990)

Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery
por: Miller, Heather, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2j4s6hchn6tignb82hp6nmopqb